The stock price of Twist Bioscience Corporation (NASDAQ: TWST) has jumped by 5.06 compared to previous close of 14.24. Despite this, the company has seen a gain of 14.11% in its stock price over the last five trading days.
Is It Worth Investing in Twist Bioscience Corporation (NASDAQ: TWST) Right Now?
Moreover, the 36-month beta value for TWST is 1.15. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 1 as “sell.”
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The average price recommended by analysts for Twist Bioscience Corporation (TWST) is $21.25, which is $9.92 above the current market price. The public float for TWST is 56.00M and currently, short sellers hold a 24.70% of that float. On May 26, 2023, TWST’s average trading volume was 1.40M shares.
TWST’s Market Performance
TWST stock saw an increase of 14.11% in the past week, with a monthly gain of 19.11% and a quarterly increase of -22.00%. The volatility ratio for the week is 9.85%, and the volatility levels for the last 30 days are 8.02% for Twist Bioscience Corporation (TWST).. The simple moving average for the past 20 days is 14.55% for TWST’s stock, with a -43.24% simple moving average for the past 200 days.
TWST Trading at 6.64% from the 50-Day Moving Average
After a stumble in the market that brought TWST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.54% of loss for the given period.
Volatility was left at 8.02%, however, over the last 30 days, the volatility rate increased by 9.85%, as shares surge +20.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.69% lower at present.
During the last 5 trading sessions, TWST rose by +14.11%, which changed the moving average for the period of 200-days by -69.17% in comparison to the 20-day moving average, which settled at $13.19. In addition, Twist Bioscience Corporation saw -37.17% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TWST starting from Cho Dennis, who purchase 10,000 shares at the price of $13.20 back on May 10. After this action, Cho Dennis now owns 29,297 shares of Twist Bioscience Corporation, valued at $132,000 using the latest closing price.
Starovasnik Melissa A., the Director of Twist Bioscience Corporation, sale 1,732 shares at $26.45 during a trade that took place back on Feb 09, which means that Starovasnik Melissa A. is holding 11,340 shares at $45,820 based on the most recent closing price.
Stock Fundamentals for TWST
Current profitability levels for the company are sitting at:
- -122.33 for the present operating margin
- +41.38 for the gross margin
The net margin for Twist Bioscience Corporation stands at -107.02. The total capital return value is set at -32.59, while invested capital returns managed to touch -28.96. Equity return is now at value -27.80, with -23.00 for asset returns.
Based on Twist Bioscience Corporation (TWST), the company’s capital structure generated 12.02 points at debt to equity in total, while total debt to capital is 10.73. Total debt to assets is 9.87, with long-term debt to equity ratio resting at 10.30. Finally, the long-term debt to capital ratio is 9.19.
When we switch over and look at the enterprise to sales, we see a ratio of 1.77, with the company’s debt to enterprise value settled at 0.06. The receivables turnover for the company is 5.91 and the total asset turnover is 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.58.
Conclusion
To wrap up, the performance of Twist Bioscience Corporation (TWST) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
